Claims for obesity drugs increased 42% in 2023, 92% since 2020: report
The use of obesity medications among Canadian employer-sponsored benefits plan members has grown substantially, with claims increasing 42 per cent in 2023 and roughly 92…
- By: Lauren Bailey
- June 7, 2024 June 6, 2024
- 09:00












